Diabetic Neuropathy Market: Approval of Novel Drugs to Push Revenue Growth Forecast 2020 to 2025

The approval of novel drugs for the treatment of diabetic neuropathic pain has led to a major uptick in the diabetic Neuropathy market. In 2015, the FDA approved Nucynta ER for the treatment of neuropathic pain caused by diabetes. Another drug, Lyrica, has also been approved for neuropathic pain treatment in 130 countries. On the back of these trends, the global diabetic neuropathy is anticipated to grow at a CAGR of 5.6% during the forecast period (2020-2025).

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4698

The recent COVID-19 pandemic is not anticipated to limit production of novel drugs or supplies of insulin to hospitals or pharmacies, attributed to increased functional capacity of manufacturing plants of leading players across the world. However, delays in processing orders may be anticipated.

Peripheral & Proximal Neuropathy to Register Major Usage of Diabetic Neuropathy Formulations

The peripheral neuropathy disorder segment is projected to find increased usage of diabetic neuropathy formulations. The scope for peripheral neuropathy drugs is poised to increase, as the treatment for peripheral neuropathy is currently confined on managing pain rather than regeneration of nerves. Moreover, under diagnoses of peripheral neuropathic patients will broaden prospects of these drugs. Projections indicate a positive CAGR of 5.9% and a market share greater than half.

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=4698

However, proximal neuropathy disorders are anticipated to find substantial applications of diabetic neuropathy formulations. Proximal neuropathy is the most common disorder among type 2 diabetics. An increase in the patient pool suffering from proximal neuropathy is thus anticipated to drive diabetic neuropathy drugs and formulations for the disorder, capturing a market share of nearly one-fourth and expanding at a CAGR of 5.6% through 2025.

diabetic neuropathy market size us$ forecast by disorder type

To connect an Expert –   https://www.factmr.com/connectus/sample?flag=AE&rep_id=4698

The Diabetic Neuropathy market report answers important questions which include:

  • What does the status of the Diabetic Neuropathy market look like after the forecast period?
  • Which region has the highest contribution to the global Diabetic Neuropathy market and why?
  • Which players remain at the top of the global Diabetic Neuropathy market?
  • What opportunities are available for the Diabetic Neuropathy market players to expand their production footprint?
  • Which segment has the maximum impact on the global Diabetic Neuropathy market?

Why Opt For Fact.MR?

  1. Various analysis methods to deliver precise market information.
  2. Digital technologies to facilitate clients with updated market solutions.
  3. Multi-disciplinary approach to provide accurate insights of different industries.
  4. Data collection from extensive primary and secondary research.
  5. Round-the-clock availability to serve clients across the world.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Prepackaged Medical Kits and Trays Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/5413/prepackaged-medical-kits-and-trays-market

Cables and Leads for Medical Equipment Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/5418/cables-and-leads-for-medical-equipment-market

Coatings for Medical Devices Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/5421/coatings-for-medical-devices-market

Read More Trending Reports of Fact.MR-


About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website:

Matched content

Editor’s pick

Express Press Release Distribution